V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Row
H
HIMSAI Stock Diagnostic Report

Hims CEO responds to FTC suit, sees GLP-1 prices falling to $40-$50: CNBC

The CEO of Hims responded to the FTC lawsuit and revealed expectations for a decline in GLP-1 drug prices.

View Source Article ↗
AI CATALYST SCORE50 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

HIMS Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-08-21 21:34:43HIMS40RowView Report →
2026-08-19 13:35:35HIMS65MidView Report →
2026-08-18 18:48:10HIMS50RowView Report →
View Full History for HIMS (Blueprint) →